Kronos Bio has appointed Marni Kottle as SVP of corporate communications and investor relations. Previously, Kottle served as VP of corporate communications at Gilead Sciences, where she steered financial communications and the corporate brand.

“With her expertise in corporate public relations, industry background and experience as a reporter, [Marni] will be instrumental in shaping our communications strategy, as we advance our pipeline of oncology drug candidates,” Norbert Bischofberger, Kronos Bio president and CEO, said in a statement.